vs
Apellis Pharmaceuticals, Inc.（APLS）与COVENANT LOGISTICS GROUP, INC.（CVLG）财务数据对比。点击上方公司名可切换其他公司
COVENANT LOGISTICS GROUP, INC.的季度营收约是Apellis Pharmaceuticals, Inc.的1.5倍（$307.2M vs $199.9M），COVENANT LOGISTICS GROUP, INC.净利率更高（1.4% vs -29.5%，领先30.9%），COVENANT LOGISTICS GROUP, INC.同比增速更快（14.0% vs -5.9%），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs 3.4%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
圣约物流集团（Covenant Logistics Group, Inc.）是一家美国公路货运企业，总部位于田纳西州查塔努加，在纽约证券交易所上市。公司核心业务涵盖温控卡车运输、区域配送以及长途团队司机货运服务，专注于整车运输领域。
APLS vs CVLG — 直观对比
营收规模更大
CVLG
是对方的1.5倍
$199.9M
营收增速更快
CVLG
高出20.0%
-5.9%
净利率更高
CVLG
高出30.9%
-29.5%
两年增速更快
APLS
近两年复合增速
3.4%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $307.2M |
| 净利润 | $-59.0M | $4.4M |
| 毛利率 | — | — |
| 营业利润率 | -25.6% | 2.0% |
| 净利率 | -29.5% | 1.4% |
| 营收同比 | -5.9% | 14.0% |
| 净利润同比 | -62.2% | -32.7% |
| 每股收益（稀释后） | $-0.40 | $0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSCVLG
| Q1 26 | — | $307.2M | ||
| Q4 25 | $199.9M | $295.4M | ||
| Q3 25 | $458.6M | $296.9M | ||
| Q2 25 | $178.5M | $302.9M | ||
| Q1 25 | $166.8M | $269.4M | ||
| Q4 24 | $212.5M | $277.3M | ||
| Q3 24 | $196.8M | $287.9M | ||
| Q2 24 | $199.7M | $287.5M |
净利润APLSCVLG
| Q1 26 | — | $4.4M | ||
| Q4 25 | $-59.0M | — | ||
| Q3 25 | $215.7M | $9.1M | ||
| Q2 25 | $-42.2M | $9.8M | ||
| Q1 25 | $-92.2M | $6.6M | ||
| Q4 24 | $-36.4M | — | ||
| Q3 24 | $-57.4M | $13.0M | ||
| Q2 24 | $-37.7M | $12.2M |
营业利润率APLSCVLG
| Q1 26 | — | 2.0% | ||
| Q4 25 | -25.6% | -8.2% | ||
| Q3 25 | 48.7% | 2.7% | ||
| Q2 25 | -18.6% | 3.8% | ||
| Q1 25 | -50.0% | 2.8% | ||
| Q4 24 | -12.3% | 3.1% | ||
| Q3 24 | -24.0% | 5.6% | ||
| Q2 24 | -14.7% | 5.4% |
净利率APLSCVLG
| Q1 26 | — | 1.4% | ||
| Q4 25 | -29.5% | — | ||
| Q3 25 | 47.0% | 3.1% | ||
| Q2 25 | -23.6% | 3.2% | ||
| Q1 25 | -55.3% | 2.4% | ||
| Q4 24 | -17.1% | — | ||
| Q3 24 | -29.2% | 4.5% | ||
| Q2 24 | -18.9% | 4.2% |
每股收益（稀释后）APLSCVLG
| Q1 26 | — | $0.17 | ||
| Q4 25 | $-0.40 | $-0.68 | ||
| Q3 25 | $1.67 | $0.35 | ||
| Q2 25 | $-0.33 | $0.36 | ||
| Q1 25 | $-0.74 | $0.24 | ||
| Q4 24 | $-0.30 | $0.25 | ||
| Q3 24 | $-0.46 | $0.47 | ||
| Q2 24 | $-0.30 | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $370.1M | $407.6M |
| 总资产 | $1.1B | $1.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APLSCVLG
| Q1 26 | — | — | ||
| Q4 25 | $466.2M | $4.9M | ||
| Q3 25 | $479.2M | $2.7M | ||
| Q2 25 | $370.0M | $143.0K | ||
| Q1 25 | $358.4M | $11.2M | ||
| Q4 24 | $411.3M | $35.6M | ||
| Q3 24 | $396.9M | $35.2M | ||
| Q2 24 | $360.1M | $1.3M |
总债务APLSCVLG
| Q1 26 | — | — | ||
| Q4 25 | — | $261.7M | ||
| Q3 25 | — | $233.3M | ||
| Q2 25 | — | $245.8M | ||
| Q1 25 | — | $216.3M | ||
| Q4 24 | — | $221.6M | ||
| Q3 24 | — | $231.4M | ||
| Q2 24 | — | $235.0M |
股东权益APLSCVLG
| Q1 26 | — | $407.6M | ||
| Q4 25 | $370.1M | $404.0M | ||
| Q3 25 | $401.2M | $423.7M | ||
| Q2 25 | $156.3M | $416.9M | ||
| Q1 25 | $164.2M | $443.6M | ||
| Q4 24 | $228.5M | $438.3M | ||
| Q3 24 | $237.1M | $431.6M | ||
| Q2 24 | $264.3M | $419.4M |
总资产APLSCVLG
| Q1 26 | — | $1.0B | ||
| Q4 25 | $1.1B | $1.0B | ||
| Q3 25 | $1.1B | $1.0B | ||
| Q2 25 | $821.4M | $1.0B | ||
| Q1 25 | $807.3M | $980.0M | ||
| Q4 24 | $885.1M | $997.6M | ||
| Q3 24 | $901.9M | $1.0B | ||
| Q2 24 | $904.5M | $995.0M |
负债/权益比APLSCVLG
| Q1 26 | — | — | ||
| Q4 25 | — | 0.65× | ||
| Q3 25 | — | 0.55× | ||
| Q2 25 | — | 0.59× | ||
| Q1 25 | — | 0.49× | ||
| Q4 24 | — | 0.51× | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | 0.56× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | — |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | — |
| 自由现金流率自由现金流/营收 | -7.1% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $45.0M | — |
8季度趋势，按日历期对齐
经营现金流APLSCVLG
| Q1 26 | — | — | ||
| Q4 25 | $-14.2M | $25.5M | ||
| Q3 25 | $108.5M | $41.4M | ||
| Q2 25 | $4.4M | $21.9M | ||
| Q1 25 | $-53.4M | $24.8M | ||
| Q4 24 | $19.4M | $21.9M | ||
| Q3 24 | $34.1M | $56.9M | ||
| Q2 24 | $-8.3M | $22.4M |
自由现金流APLSCVLG
| Q1 26 | — | — | ||
| Q4 25 | $-14.3M | $-3.0M | ||
| Q3 25 | $108.3M | $-7.8M | ||
| Q2 25 | $4.4M | $-14.5M | ||
| Q1 25 | $-53.4M | $-8.6M | ||
| Q4 24 | $19.3M | $464.0K | ||
| Q3 24 | — | $24.3M | ||
| Q2 24 | $-8.4M | $-28.1M |
自由现金流率APLSCVLG
| Q1 26 | — | — | ||
| Q4 25 | -7.1% | -1.0% | ||
| Q3 25 | 23.6% | -2.6% | ||
| Q2 25 | 2.5% | -4.8% | ||
| Q1 25 | -32.0% | -3.2% | ||
| Q4 24 | 9.1% | 0.2% | ||
| Q3 24 | — | 8.4% | ||
| Q2 24 | -4.2% | -9.8% |
资本支出强度APLSCVLG
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 9.7% | ||
| Q3 25 | 0.0% | 16.6% | ||
| Q2 25 | 0.0% | 12.0% | ||
| Q1 25 | 0.0% | 12.4% | ||
| Q4 24 | 0.0% | 7.7% | ||
| Q3 24 | 0.0% | 11.3% | ||
| Q2 24 | 0.0% | 17.6% |
现金转化率APLSCVLG
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.50× | 4.55× | ||
| Q2 25 | — | 2.23× | ||
| Q1 25 | — | 3.78× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 4.36× | ||
| Q2 24 | — | 1.84× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
CVLG
| Freight revenue | $281.9M | 92% |
| Other | $25.2M | 8% |
